Frailty and Risk of Serious Infections in Biologic-treated Patients With Inflammatory Bowel Diseases.

Siddharth SinghHerbert C HeienLindsey SangaralinghamNilay D ShahJennifer C LaiWilliam J SandbornAlison A Moore

Published in: Inflammatory bowel diseases (2022)

In biologic-treated patients with IBD, frailty assessed using a claims-based frailty index was not independently associated with increased risk of serious infections. Future studies evaluating objective and biological measures of frailty are warranted to risk-stratify older patients with IBD.

Keyphrases

community dwelling
rheumatoid arthritis
newly diagnosed
ulcerative colitis
current status
middle aged